Levosimendan for the treatment of acute severe heart failure: A meta-analysis of randomised controlled trials
- 4 February 2010
- journal article
- research article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 138 (3), 281-289
- https://doi.org/10.1016/j.ijcard.2008.08.020
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Ethical authorship and publishingInternational Journal of Cardiology, 2009
- Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failureHeart, 2006
- Levosimendan in Cardiac Surgery: Current Best Available EvidenceThe Annals of Thoracic Surgery, 2006
- Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunctionAmerican Heart Journal, 2005
- Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)American Heart Journal, 2005
- Pharmacokinetics and Pharmacodynamics of Intravenous Inotropic AgentsClinical Pharmacokinetics, 2004
- Do β-blockers prolong survival in heart failure only by inhibiting the β1-receptor? A perspective on the results of the COMET trialJournal of Cardiac Failure, 2003
- Measuring inconsistency in meta-analysesBMJ, 2003
- Issues in the selection of a summary statistic for meta‐analysis of clinical trials with binary outcomesStatistics in Medicine, 2002
- Meta‐analyses in systematic reviews of randomized controlled trials in perinatal medicine: comparison of fixed and random effects modelsStatistics in Medicine, 2001